SILVER SPRING, MD  -  AUGUST 20, 2019  -  Dr. Michael Bevilacqua, Amicrobe’s founder and CEO, was an invited to participate as a panelist at the FDA workshop entitled "Understanding the Development of Non-Traditional Therapies for Bacterial Infection." The workshop focused on discussion of the landscape and important regulatory challenges associated with various areas of non-traditional therapies.

​

​

​

​